Pancreatic cancer put to the test by radiofrequency at the Arnault Tzanck Institute and the Nice University Hospital
Only 5% to 10% of pancreatic cancers are eligible for radiofrequency treatment. » From the outset, Dr. Adrien Sportes, a gastroenterologist at the Arnault Tzanck Institute (IAT) in Saint-Laurent-du-Var, wants to specify the indications so as not to create vain hopes among the nearly 16,000 French people who, each year, are diagnosed with cancer of … Read more